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Uterine Natural Killer Cell
Heterogeneity: Lessons From Mouse
Models
Dorothy K. Sojka*
Rheumatology Division, Washington University School of Medicine, St. Louis, MO, United States
Natural killer (NK) cells are themost abundant lymphocytes at thematernal-fetal interface.
Epidemiological data implicate NK cells in human pregnancy outcomes. Discoveries
using mouse NK cells have guided subsequent advances in human NK cell biology.
However, it remains challenging to identify mouse and human uterine NK (uNK) cell
function(s) because of the dynamic changes in the systemic-endocrinological and
local uterine structural microenvironments during pregnancy. This review discusses
functional similarities and differences between mouse and human NK cells at the
maternal-fetal interface.
Keywords: conventional NK cells, pregnancy, maternal-fetal interface, tissue-resident NK cells, uterine NK cells
INTRODUCTION
Concinnity, the harmonious arrangement of different parts skillfully fitting together, is a word
that describes the orchestrated changes that occur between mother and conceptus during
pregnancy. The coordinated modifications are supported by the maternal immune system
which accommodates the genetically distinct individual. There is no direct contact between
the circulations of the mother and the conceptus; however, conceptus-derived extraembryonic
membranes evolve into the chorioallantoic placenta and the chorioamnion, both directly bordering
maternal tissues of the uterine cavity. As these maternal-fetal boundaries are established,
uterine immune cells provide support. Survival of mammalian species defies the classic laws of
transplantation immunology.
Mammalian reproductive success depends on tightly-regulated signal coordination that lead
to the optimal vascular perfusion of a placenta that supports the fetus. In humans, abnormal
spiral artery development is associated with obstetrical syndromes such as preeclampsia (1),
a hypertensive disorder that affects 3–7% of pregnancies. Epidemiological evidence associates
preeclampsia with specific maternal natural killer (NK) cell receptors and their cognate human
leukocyte antigen class I (HLA-I) ligands expressed by conceptus cells (2–4). The most abundant
maternal leukocytes at the maternal-fetal interface are uterine NK (uNK) cells. Therefore,
epidemiological data strongly suggest that uNK cells have crucial roles in remodeling the maternal
vessels that support placental development and function over pregnancy.
NK cells express killer Ig-like receptors in human (KIRs) and lectin-like receptors in mouse
(Ly49s), which are the primary major histocompatibility complex class I (MHC-I)-specific
inhibitory receptors. Pregnant women with a specific KIR haplotype carrying a conceptus with a
specific HLA-C genotype have significantly greater risk for preeclampsia (2). Expanded evidence
for the negative effects of inhibitory receptors on NK cells interacting with their MHC-I ligands
on fetal tissues was obtained from a cohort of African women, who have more genetic diversity in
KIR haplotypes and HLA alleles (4). Studies associating specific maternal KIR and conceptus HLA
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alleles with preeclampsia strongly suggest a precise role
for NK cell receptors that recognize fetal MHC-I, although
further in vivo human studies would be challenging. In mice,
specific maternal-fetal MHC-I haplotype combinations display
differences in decidual vessels, placental sizes, and fetal weights
(5, 6). Thus, studies of murine NK cells can be used to
guide future translational investigations of human pregnancy
complications despite species-specific differences between the
pregnancies (7, 8).
MATERNAL-FETAL INTERFACE
Human and mouse pregnancies induce environmental changes
in uterus that establish receptivity and implantation (9). The
maternal-fetal interface includes maternally-derived decidua
basalis and conceptus-derived placenta. In humans, endometrial
decidualization occurs each menstrual cycle and is shed if
implantation does not take place (10). If implantation occurs
the decidual cells proliferate, contact invading extravillous
trophoblasts (EVTs) and form the decidua basalis. Unobstructed
maternal blood flow into the intervillous space occurs between
10 and 12 weeks, marking the end of the first trimester. In
mice, blastocyst implantation triggers decidualization, where
uterine stromal cells are transformed into large decidual cells that
proliferate to surround the implantation site then become the
decidua basalis. In both species, decidualization is accompanied
by vascular changes and leukocyte accumulation, largely NK
cells (11, 12). At gestational day 9.5, the murine labyrinthine
placenta accepts maternal blood flow and supplies nutrients
to the fetus for the remainder of the pregnancy. At this time
the mesometrial aggregate of pregnancy (MLAp) forms in the
maternal uterine wall of mice but not human (11). The definitive
chorioallantoic placenta develops, accompanied by vascular
remodeling of the subjacent uterine arteries. The maternal-fetal
interface is well established by first trimester (humans) and
mid-pregnancy (mice).
PLACENTAL DEVELOPMENT AND
FUNCTION
A placenta anchors each conceptus to the uterine wall, is the site
of nutrient, gas, and waste exchange, and induces an immune
environment that nurtures and protects the fetus (13, 14).
Placental dysfunction results in human pregnancy complications
that associate with long-term health consequences for both
mother and baby. The fetal origins hypothesis, coined by David
J.P. Barker [known as the Developmental Origins of Human
Adult Disease (DOHAD)], posits that in utero fetal programming
mediated by placental function has life-long effects on the baby’s
health (15, 16). Thus, placenta is pivotal not only to fetal
development but also offspring health.
While placental structural anatomy varies, in all species the
placenta arises from the trophectoderm of the preimplantation
blastocyst (17). This layer is programmed to differentiate into
fetal membranes while the inner cell mass of the blastocyst
evolves the fetus. The mammalian placenta is categorized based
on histological structure of the maternal-fetal interface. There
are three placental classifications that includes: epitheliochorial
(cow, horse, pig), endotheliochorial (dog, cat), and hemochorial
(human, rodent). Hemochorial is the most invasive type, in
which fetal trophoblast cells invade deeply into the maternal
endometrium and vasculature to establish maternal blood
perfusion through the placenta.
Hemochorial Placenta
Human and mouse hemochorial placentas share many features,
but differ in ways that affect immunity. The human placenta is
structured as chorionic villous trees that are bathed in maternal
blood. A single layer of multinucleated syncytiotrophoblast
(SynT) surfaces human placental villous trees and lines the
intervillous space perfused by maternal blood. Mononucleated
cytotrophoblasts are undifferentiated progenitor cells, subjacent
to the SynT, that differentiate and fuse to replenish the SynT.
Other cytotrophoblasts differentiate into EVTs, which are located
at tips of the anchoring villi and invade the decidua basalis and
maternal decidual vessels. During first and into early second
trimester, human placental villi are hemodichorial, covered with
a continuous bilayer of SynT and cytotrophoblasts. The villous
cytotrophoblast layer becomes discontinuous during the second
trimester yielding a hemomonochorial structure with only a SynT
cell barrier between fetal and maternal blood.
In mouse, the definitive chorioallantoic placenta is
labyrinthine with two separate, maze-like vascular systems.
Branches of the central arteries traverse the junctional zone then
perfuse the fetal labyrinth with maternal blood. The irregularly-
shaped junctional zone lies between the decidua basalis and
labyrinth. The labyrinth is surfaced by two syncytial layers of
trophoblast (SynT I and II) and a mononuclear trophoblast
layer adjacent to the maternal blood. The labyrinthine structure
comprises the interhemal unit, which continuously thins
during gestation. Scanning electron microscopy indicates that
midgestational mouse placenta is hemodichorial, with direct
maternal blood contact of SynT-I as the cellular trophoblast
layer becomes incomplete, exposing areas of SynT-II (18). These
differences in cellular composition and placental structure
may alter immunity at the maternal-placental interface. Thus,
mechanisms that protect fetuses from an activated maternal
immune system, and block access of maternally circulating
pathogens to the fetus may differ spatiotemporally in human and
mouse gestations.
Immunological Interface
Typically, placental membranes separate the semi-allogenic fetus
from the maternal immune system throughout gestation, an
arrangement that protects against maternal, immune-mediated
elimination of the fetus. Multiple immunological interfaces occur
between the placenta and maternal immune system. One such
interface is between the trophoblast cells that line the chorionic
villi (human) and labyrinth structure (mouse) that bathe in
maternal blood (Figure 1-II). In human placentas, the SynT
cells exposed to maternal blood do not express MHC-I or
MHC-II, and do not elicit maternal T cell responses. In mouse
placentas, the MHC expression on labyrinthine trophoblast
Frontiers in Immunology | www.frontiersin.org 2 February 2020 | Volume 11 | Article 290
Sojka Uterine Natural Killer Cell Heterogeneity
FIGURE 1 | Immunological interfaces of the mouse and human placentas. Schematic diagram of placenta positioned with maternal tissues above fetal tissues. The
murine (left panel) and human (right panel) placenta. The top inset (I) shows the cellular components of midgestation decidua basalis. In mouse and human decidua
basalis, NK cell subsets are in close contact with decidua cells, invading interstitial trophoblast cells and other immune cells such as macrophages and dendritic cells.
The bottom inset (II) shows the interhemal membrane unit in the placental labyrinth and chorionic villi. The sinusoidal trophoblast giant cells (mouse) and
syncytiotrophoblast cells (human) line the maternal blood sinus and are exposed to circulating immune cells among them, cNK cells. In human placentas, the bottom
inset (III), shows the endovascular trophoblast invasion where EVTs remodel the maternal vasculature and are exposed to circulating immune cells. Abbreviations in
figure: parietal trophoblast giant cells (P-TGCs), junctional zone (JZ), tissue-resident NK cell (trNK), conventional NK cell (cNK), peripheral blood (pNK) cells, decidual
NK (dNK) cells, extravillous trophoblasts (EVT).
is less clear. A second immunological interface occurs in
the decidualized endometrium. In a process called interstitial
trophoblast invasion the EVTs in human and extra labyrinthine
trophoblasts in mice are intimately positioned to interact with
the maternal immune cells. For example, EVTs express the
class I molecule HLA-C and non-classical class I molecules
HLA-E and HLA-G. HLA-C, HLA-E, and HLA-G interact with
KIR and CD94/NKG2 receptors expressed in NK cells. HLA-G
binds, members of the immunoglobulin-like transcript (ILT)
ILT2 and ILT4, a family of receptors expressed in NK cells
to induce growth factors important for fetal development (19).
Invading giant trophoblast cells (TGCs) in mouse do not express
non-classical MHC-I molecules (20, 21); however, TGCs that
potentially contact immune cells in the decidua basalis of
the C57BL/6J B6 mice do express the classical MHC-I, H-2K
(Figure 1-I). Finally, in human placentas during endovascular
trophoblast invasion, the EVTs hijack and transform thematernal
circulatory system to yield high capacitance, low resistance
arterial flow in the placenta and interact with circulating
immune cells (Figure 1-III). Hence, the different immunological
interfaces, with differential expression of paternally-inherited
MHC receptors, may elicit distinct maternal immune responses
such as systemic responses to SynT, or local tissue-specific
responses to invading trophoblasts, or both.
NK CELLS IN PREGNANCY
During pregnancy, uNK cells dominate at the implantation site in
species with hemochorial placentation (9, 22–24). Approximately
70% of lymphocytes at the maternal-fetal interface are uNK
cells during early human and mouse gestation; this percentage
declines after mid-pregnancy (25). Histologically, uNK cells
are localized to human decidua basalis and mouse junctional
zone and MLAp (26, 27). Notably, they are essentially absent
from the mouse placental labyrinth (27). Here, “uNK” cells
will refer to NK cells in human and mouse implantation sites.
Emerging evidence indicates that uNK cells are heterogeneous
and contribute to pregnancy success, although they are
phenotypically and functionally distinct from conventional NK
cells in the circulation (28–31).
cNK Cells
NK cells are the originating members of an assortment of
innate lymphoid cells (ILCs). NK cells are a heterogeneous
population in the spleen, circulating blood, and many tissues
(27, 32–34). Historically, most studies investigated conventional
NK (cNK) in mouse spleen and human peripheral blood. NK
cells do not express antigen-specific T-cell receptors (TCRs) or
B-cell receptors (BCRs), distinguishing them from the adaptive
immune system (35, 36). Developmental studies indicate that all
ILC lineages arise from common lymphoid progenitors (CLPs)
(37, 38). CLPs differentiate into NK cells, ILC1s, ILC2s, ILC3s
and lymphoid tissue inducer (LTi) cells (39, 40). The common
helper ILC precursor (CHILP), the progenitor to all helper-like
ILC lineages, gives rise to ILC1s, ILC2s, and ILC3s, but not LTi
cells or NK cells (41). This separates cNK cell development from
other ILCs and ensures that cytotoxic NK cells are distinct from
ILC1s (38).
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FIGURE 2 | Parabiosis model. (A) Schematic of two congenically marked animals that were surgically joined together. C57BL/6J (CD45.2) mice were parabiosed to
congenic B6-Ly5.1 (CD45.1) mice. The organs were harvested on day 14 post-parabiosis surgery and analyzed using flow cytometry. A representative dot plot of the
virgin uterus (B) or spleen (C) gated on live CD3− CD4− NK1.1+ cells followed by a CD45.1 gate (left panels) and CD45.2 gate (right panels) in the CD45.1 parabiont.
The percentages of CD49a+ and DX-5+ are depicted in the dot plots.
trNK Cells
We identified tissue-resident NK (trNK) cell populations in
mouse liver, skin, and virgin uterus that are distinct from cNK
cells (32). The trNK cells do not circulate in parabiotic mice,
whereas cNK cells circulate (Figure 2). Phenotypic and RNA-seq
analyses revealed that trNK and cNK cells express CD49a and
DX5, respectively (32, 33). Liver trNK cells lack Eomesodermin
(Eomes), a transcription factor expressed in cNK cells. Nfil3−/−
mice have trNK cells in liver, skin, and virgin uterus, but lack
cNK cells. Tbx21−/− mice lack trNK cells in liver and skin,
whereas cNK cell distribution is relatively unaffected at these
tissues. In virgin uteri, trNK cells dominate over cNK cells and
are unaffected in Nfil3−/− and Tbx21−/− mice. Ly49 receptor
expression repertoires differ between trNK and cNK cells; liver
trNK cells do not express Ly49D or Ly49H. Although trNK cells
have an immature phenotype, they have more diverse cytokine
production than cNK cells. Thus, trNK and cNK cells represent
divergent NK cell lineages, with a distinct trNK cell lineage in
virgin uterus differing not only from cNK cell but also from
liver/skin trNK cells (32).
Conversion of cNK Cells
Although trNK and cNK cells represent different lineages, recent
studies suggest cNK cell conversion to NK cells phenotypically
similar to liver ILC1 cells (42). For example, mouse CD49a−
DX5+ Eomes+ cNK cells can change their phenotype in a
tumor microenvironment to become CD49a+ DX5− Eomesint,
while, cNK cells convert into ILC1-like cells during Toxoplasma
gondii infection (43). Human peripheral blood (pb) NK cells
and hematopoietic progenitor cells isolated from decidual tissue
also convert in vitro to a decidual NK cell phenotype (44, 45).
It is currently unknown whether cNK cell conversion occurs
in pregnancy.
Origin of uNK Cells
Despite differences in gestational lengths (9 months in humans
vs. 19.5 days in C57BL/6J mice) and placental structure, early
pregnancy consistently triggers lymphocyte accumulation within
successful implantation sites (23, 46). Although uNK cells are
ultimately derived from bone marrow (26, 47), studies using
immunocompetent donor and alymphoid recipient mice report
uNK cell accumulation during pregnancy using uterine segment
transplants (48, 49) or adoptive splenocyte transfer (48). These
results indicate uterine homing of peripheral NK cells when
the uterus lacked endogenous uNK cells. These findings were
challenged when adoptively transferred splenic NK cells failed
to home to a syngeneic, immunocompetent pregnant uterus,
indicating expansion of resident progenitor NK cells (50). We
recently used the parabiosis model together with experimentally-
induced decidualization to study early pregnancy events and
demonstrated that trNK cells do not circulate. Rather, trNK cells
proliferate locally and expand the uNK cell pool with minimal
cNK cells contributions (13, 27). These data support a two-wave
hypothesis for uNK cell accumulation during typical pregnancies
(13, 27, 51). The first wave involves local proliferation of trNK
cells during decidualization; the second wave postulates the
accumulation of cNK cells recruited into the decidua basalis
during placentation. Whether or not trNK cells contribute to
the NK cell pool of early human pregnancy remains unknown
(discussed below).
Human NK Cells
In first trimester human pregnancy, NK cells represent
∼70% of the lymphocytes present in decidua basalis and are
phenotypically and functionally distinguished from pbNK cells.
Human uNK (often referred to as decidual NK cells, dNK)
cells are CD56bright CD16−KIR+CD9+CD49a+ while pbNK cells
are CD56dimCD16+KIR+ (52). Compared to pbNK cells, uNK
cells are not cytotoxic, produce lower amounts of IFN-γ and,
as in mouse, secrete VEGF that promotes angiogenesis (28,
53, 54). Single-cell RNA sequencing comparing cells isolated
from first trimester decidual basalis and matched peripheral
blood demonstrated three distinct NK cell subsets in decidua
basalis, dNK1-3, distinct from pbNK cells (55). High dimensional
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CyTOF analysis found dNK1-3 mixed with populations of
proliferating dNK, dILC3 and pbNK cells suggestive of mixed
origins of decidual lineages (31). The dNK1 cells resembled a
recently identified “pregnancy trained dNK cell” subset found in
repeated pregnancy (56) similarly to expanded ILC1s of mouse
second pregnancy (57). Mouse models should be instrumental in
clarifying the functional contributions of each uNK cell subset at
the maternal-fetal interface.
NK CELL FUNCTION IN PREGNANCY
Arterial Remodeling
Understanding of how human uNK cells affect pregnancy and the
placental vasculature has been challenging; however, studies of
mouse uNK cells have been informative. Several mouse genetic
models deficient in NK cells display aberrant modification of the
uterine gestational vasculature, as their strongest reproductive
phenotype. Rag2−/−gc−/− alymphoid mice, display defective
spiral artery remodeling during pregnancy (58) but no defects
in implantation (59). The arterial defects were rescued in bone
marrow (BM) chimeric mice when Rag2−/− gc−/− recipients
received wild-type BM but not BM from interferon-γ-deficient
mice. Similarly, Nfil3−/− mice that lack cNK cells (32), have
a smaller MLAp, aberrant uterine arterial modifications, and
smaller pups (60, 61). Roles for interferon-γ in dNK cell-
mediated vessel modification have not been confirmed in human
studies. In the first trimester, uterine artery Doppler ultrasound
screening can be used to identify women with poor spiral arterial
remodeling predicting greater risk for preeclampsia and fetal
growth restriction (62). Using in vitro analysis of EVT lines and
primary explant cultures, dNK cells from the typical pregnancies
promoted trophoblast motility and invasion while dNK cells
from women identified as high risk for preeclampsia limited
trophoblast function (63). Taken together, human and murine
placental pathology supports that vascular remodeling defects
are associated with preeclampsia and fetal growth restriction and
linked to deficits in uNK cells numbers or functions (64, 65).
Border Control at the Maternal-Fetal
Interface
Establishing hemochorial placentation requires aggressive
invasion by trophoblast cells. Human trophoblasts show
interstitial invasion, penetrating the uterine epithelium and
expanding in the subjacent decidua. Rodent trophoblast invasion
is significant but not as deep as human (66). Modifications of
maternal blood flow are established by endovascular trophoblast
invasion of implantation site decidual vessels. In humans
and rats, interstitial and endovascular trophoblast invasion
both extend past the decidua basalis and penetrate the inner
myometrium. In mice, trophoblast invasion is interstitial and
limited to the junctional zone (67). Uncontrolled trophoblast
invasion that penetrates beyond the decidua into the myometrial
muscle creates the life-threatening pregnancy complication
called placenta accreta. A recently reported dystocia mouse
model resembles human placenta accreta (60). The phenotype
includes stillbirths, hemorrhage, and undelivered placentas.
Histopathology revealed excessive trophoblast invasion and
reduced numbers of trNK cells (68). In this model, a deficiency in
the signaling adaptor molecule Grb2-associated binding protein
3 (Gab3) was important for trNK cell proliferation in response
to local cytokine (IL15) stimulation. A similar outcome of
dysregulated trophoblast invasion occurs in a rat model of IL15
deficient NK cells (69). These results suggest that defects in trNK
cell proliferation lead to interstitial trophoblast hyperinvasion
and provide insights into placenta accreta.
MOUSE MODELS
The mouse is a well-characterized genetic model system to
study NK cell biology because defined mice allow reproducible
experimental conditions. Discoveries in mouse NK cell biology
guided subsequent studies on human NK cells. For example,
Ly49A was identified as an inhibitory MHC-I–specific NK cell
receptor (70) before molecular identification of KIRs (71, 72).
Liver trNK cells were identified in mouse (32, 33) prior to
human liver trNK cell discovery (73). Endometrial sampling of
ongoing human gestation is extremely limited to the narrow
window for elective pregnancy termination. Sampling at delivery
is more accessible, but uNK cells are rare or absent by term
in both women (74, 75) and mice (76), rendering term tissue
samples inappropriate for defining normal uNK cell functions.
Therefore, animal models are crucial for insights into uNK cell
biology as complements to the sparse data available from human
implantation sites.
CONCLUSION
Integration of data derived from experimental animal models
with the limited data available from human implantation sites
is essential to advance our knowledge of uNK cell biology.
Despite their name, uNK cells are not good killers in pregnancy
but promote placentation in response to allogeneic MHC
molecules expressed on human extravillous, or mouse extra-
labyrinthine trophoblasts. Importantly, the maternal immune
system in pregnancy does not defy the classical laws of
transplantation, but actually follows these laws, in a unique and
highly modified format.
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